Related Experiment Video
Updated: Dec 7, 2025
Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
Published on: January 17, 2025
Percutaneous Left Atrial Appendage Occlusion: A View From the UK
1Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart and Chest Hospital, Liverpool, UK.
Insights
Atrial fibrillation (AF) patients face stroke risks. Left atrial appendage occlusion offers an alternative to blood thinners, with growing demand and evolving UK service delivery.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Devices
Background:
- Atrial fibrillation (AF) increases thromboembolic event risk.
- Oral anticoagulation is standard but has limitations.
- Percutaneous left atrial appendage occlusion (LAAO) is an effective alternative.
Purpose of the Study:
- To describe the use of LAAO in the UK.
- To discuss challenges in LAAO service delivery.
Main Methods:
- Review of LAAO procedures in the UK.
- Analysis of service commissioning and delivery changes.
Main Results:
- Population data indicate a clear demand for LAAO.
- Significant changes in LAAO service delivery have occurred in the UK over the past decade.
Conclusions:
- LAAO is an established alternative for AF patients.
- Ongoing challenges in LAAO implementation and service delivery require attention.
Abstract:
AF is associated with an increased risk of thromboembolic events, which is usually managed with oral anticoagulation therapy. However, despite a broad range of anticoagulant options and improved uptake in anticoagulation over the past decade, there are some limitations to this approach. Percutaneous left atrial appendage occlusion has been shown to be an effective alternative in this setting, and population data suggest a clear demand for this procedure. Over the past decade, several important changes to the commissioning and delivery of this service have occurred in the UK. In this article, the authors describe the use of percutaneous left atrial appendage occlusion in the UK and discuss the challenges that lie ahead.
